nach oben

Erschienen in:

02.03.2020 | Invited Review

Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis

verfasst von: Renato Nardi Pedro, Asad Ullah Aslam, Jibril Oyekunle Bello, Kamran Hassan Bhatti, Joseph Philipraj, Idrissa Sissoko, Giovanna Souza Vasconcellos, Alberto Trinchieri, Noor Buchholz

Erschienen in: Urolithiasis | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Nutrients, vitamins, probiotics, and herbal products may be risk factors, or alternately, protect against the formation of urinary stones. The purpose of this review was to update knowledge of the role of nutraceuticals in renal stone formation. A systematic search of the relevant literature published in PubMed in the last ten years was conducted and a narrative review of the data from the included studies was done. Search screened 513 studies that were reduced to 34 after evaluation by title and abstract; other 38 studies were retrieved by references of the selected studies. Beverages high fluid intake confirmed protective effect; orange juice protective effect; apple or grapefruit juice not confirmed as risk factors; sugar-sweetened soda and punch increased risk of stone formation. Energy intake: very high energy intake increased risk factor for women (especially after menopause); dietary acid load increased risk at equal levels of energy intake. Macronutrients confirmed increased risk of high protein intake. Calcium and Oxalate: calcium intake protective effect; oxalate intake only modest increase of risk in men and older women. Metal cations zinc and iron intake no clear impact on the risk of stone formation, dietary copper increased risk; manganese intake reduced risk of stone formation. Fruits and Vegetables decreased risk. Vitamins B6 intake not associated to risk of stone formation; vitamin C intake increased risk in men; vitamin D or supplemental vitamin D intake not associated to increased risk in men and younger women, suggestion of a higher risk in older women; Probiotics Gut colonization with Oxalobacter formigenes associated to lower risk of stone formation, effect of oxalate-degraders probiotics on urinary oxalate equivocal. Herbal products efficacy of some herbal products demonstrated in some trials, more investigations needed to confirm their efficacy and safety.

Curhan GC, Curhan SG (1994) Dietary factors and kidney stone formation. Compr Ther 20:485–489PubMed

Taylor EN, Curhan GC (2006) Diet and fluid prescription in stone disease. Kidney Int 70:835–839PubMed

Curhan GC, Willett WC, Rimm EB et al (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833–838PubMed

Curhan G, Willett W, Speizer F et al (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126:497–504PubMed

Curhan GC, Willett WC, Knight EL et al (2004) Dietary factors and the risk of incident kidney stones in younger women (Nurses’ Health Study II). Arch Intern Med 164:885–891PubMed

Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–844PubMed

Curhan GC, Willett WC, Rimm EB et al (1996) Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143:240–247PubMed

Curhan GC, Willett WC, Speizer FE et al (1998) Beverage use and risk for kidney stones in women. Ann Intern Med 128:534–540PubMed

Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, Wolfe H, Dale R, Daley M, Malik I et al (1992) Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol 45:911–916PubMed

10.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2013) Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol 8:1389–1395PubMedPubMedCentral

11.

Wabner CL, Pak CY (1993) Effect of orange juice consumption on urinary stone risk factors. J Urol 149:1405–1408PubMed

12.

Odvina CV (2006) Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol 1:1269–1274PubMed

13.

Shu X, Cai H, Xiang YB, Li H, Lipworth L, Miller NL, Zheng W, Shu XO, Hsi RS (2019) Green tea intake and risk of incident kidney stones: prospective cohort studies in middle-aged and elderly Chinese individuals. Int J Urol 26:241–246PubMed

14.

Chen HY, Wu JS, Chang YF, Sun ZJ, Chang CJ, Lu FH, Yang YC (2019) Increased amount and duration of tea consumption may be associated with decreased risk of renal stone disease. World J Urol 37:379–384PubMed

15.

Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed

16.

West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–94. Am J Kidney Dis 51:741–747PubMed

17.

Rendina D, Mossetti G, De Filippo G, Benvenuto D, Vivona CL, Imbroinise A, Zampa G, Ricchio S, Strazzullo P (2009) Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant 24:900–906PubMed

18.

Jeong IG, Kang T, Bang JK, Park J, Kim W, Hwang SS (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383–388PubMed

19.

Rendina D, De Filippo G, D'Elia L, Strazzullo P (2014) Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol 27:371–376PubMed

20.

Al Zahrani H, Norman RW, Thompson C, Weerasinghe S (2000) The dietary habits of idiopathic calcium stone-formers and normal control subjects. BJU Int 85:616–620PubMed

21.

Aune D, Mahamat-Saleh Y, Norat T, Riboli E (2018) Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 33:1033–1047PubMedPubMedCentral

22.

Sorensen MD, Chi T, Shara NM, Wang H, Hsi RS, Orchard T, Kahn AJ, Jackson RD, Miller J, Reiner AP, Stoller ML (2014) Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women’s Health Initiative. J Am Soc Nephrol 25:362–369PubMed

23.

Shu X, Cai H, Xiang YB, Li H, Lipworth L, Miller NL, Zheng W, Shu XO, Hsi RS (2017) Nephrolithiasis among middle aged and elderly urban Chinese: a report from prospective cohort studies in Shanghai. J Endourol 31:1327–1334PubMedPubMedCentral

24.

Oda E (2014) Overweight and high-sensitivity C-reactive protein are weakly associated with kidney stone formation in Japanese men. Int J Urol 21:1005–1011PubMed

25.

Yoshimura E, Sawada SS, Lee IM et al (2016) Body mass index and kidney stones: a cohort study of Japanese men. J Epidemiol 26:131–136PubMed

26.

Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN (2015) Physical activity, energy intake and the risk of incident kidney stones. J Urol 193:864–868PubMed

27.

Trinchieri A, Maletta A, Lizzano R, Marchesotti F (2013) Potential renal acid load and the risk of renal stone formation in a case-control study. Eur J Clin Nutr 67:1077–1080PubMed

28.

Vezzoli G, Dogliotti E, Terranegra A, Arcidiacono T, Macrina L, Tavecchia M, Pivari F, Mingione A, Brasacchio C, Nouvenne A, Meschi T, Cusi D, Spotti D, Montanari E, Soldati L (2015) Dietary style and acid load in an Italian population of calcium kidney stone formers. Nutr Metab Cardiovasc Dis 25:588–593PubMed

29.

Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN (2016) Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones. Clin J Am Soc Nephrol 11:1834–1844PubMedPubMedCentral

30.

Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253–2259PubMedPubMedCentral

31.

Leone A, Fernández-Montero A, de la Fuente-Arrillaga C, Martínez-González MÁ, Bertoli S, Battezzati A, Bes-Rastrollo M (2017) Adherence to the Mediterranean dietary pattern and incidence of nephrolithiasis in the Seguimiento Universidad de Navarra follow-up (SUN) cohort. Am J Kidney Dis 70:778–786PubMed

32.

Siener R, Jansen B, Watzer B, Hesse A (2011) Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation. J Urol 185:719–724PubMed

33.

Yasui T, Suzuki S, Itoh Y, Tozawa K, Tokudome S, Kohri K (2008) Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Urol Int 81:135–138PubMed

34.

Taylor EN, Stampfer MJ, Curhan GC (2005) Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis 45:267–274PubMed

35.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2017) Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol 198:858–863PubMedPubMedCentral

36.

Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE (2014) Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol 29:363–369PubMed

37.

Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84PubMed

38.

Taylor EN, Curhan GC (2007) Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 18:2198–2204PubMed

39.

Taylor EN, Curhan GC (2013) Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones. J Urol 190:1255–1259PubMedPubMedCentral

40.

Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15:3225–3232PubMed

41.

Tang J, McFann K, Chonchol M (2012) Dietary zinc intake and kidney stone formation: evaluation of NHANES III. Am J Nephrol 36:549–553PubMed

42.

Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013) Dietary cadmium exposure and kidney stone incidence: a population-based prospective cohort study of men & women. Environ Int 59:148–151PubMed

43.

Ferraro PM, Bonello M, Frigo AC, D'Addessi A, Sturniolo A, Gambaro G (2011) Cadmium exposure and kidney stone formation in the general population—an analysis of the National Health and Nutrition Examination Survey III data. J Endourol 25:875–880PubMed

44.

Ferraro PM, Gambaro G, Curhan GC, Taylor EN (2018) Intake of trace metals and the risk of incident kidney stones. J Urol 199:1534–1539PubMedPubMedCentral

45.

Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73:207–212PubMed

46.

Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F, Novarini A, Borghi L (2004) The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 66:2402–2410PubMed

47.

Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, Wang H, Hou L, Stoller ML, Women’s Health Initiative Writing Group (2014) (2014) Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women's Health Initiative report. J Urol 192:1694–1699PubMedPubMedCentral

48.

Ferraro PM, Curhan GC, Gambaro G, Taylor EN (2019) Antibiotic use and risk of incident kidney stones in female nurses. Am J Kidney Dis 74(6):736–741PubMed

49.

Curhan GC, Willett WC, Rimm EB et al (1996) A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 155:1847–1851PubMed

50.

Curhan GC, Willett WC, Speizer FE et al (1999) Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 10:840–845PubMed

51.

Letavernier E, Daudon M (2018) Vitamin D, hypercalciuria and kidney stones. Nutrients 10:pii:E366

52.

Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Investigators WHI (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683PubMed

53.

Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol JASN 15:3225–3232PubMed

54.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2018) Vitamin B6 intake and the risk of incident kidney stones. Urolithiasis 46:265–270PubMed

55.

Ferraro PM, Curhan GC, Gambaro G, Taylor EN (2016) Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones. Am J Kidney Dis 67:400–407PubMed

56.

Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnell SL (2017) Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 317:1234–1243PubMed

57.

Wallace RB, Wactawski-Wende J, O'Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K (2011) Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 94:270–277PubMedPubMedCentral

58.

Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE (2013) Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 24:567–580PubMed

59.

Malihi Z, Lawes CMM, Wu Z, Huang Y, Waayer D, Toop L, Khaw KT, Camargo CA, Scragg R (2019) Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial. Am J Clin Nutr 109:1578–1587PubMed

60.

Avenell A, Mak JC, O'Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev (4):CD000227

61.

Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev (1):CD007470

62.

Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan M (2018) Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US preventive services task force. JAMA 319:1600–1612PubMed

63.

Malihi Z, Wu Z, Stewart AW, Lawes CM, Scragg R (2016) Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis. Am J Clin Nutr 104:1039–1051PubMed

64.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2017) Vitamin D intake and the risk of incident kidney stones. J Urol 197:405–410PubMed

65.

Wei FF, Thijs L, Zhang ZY, Jacobs L, Yang WY, Salvi E, Citterio L, Cauwenberghs N, Kuznetsova T, Drummen NEA, Hara A, Manunta P, Li Y, Verhamme P, Allegaert K, Cusi D, Vermeer C, Staessen JA (2018) The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population. Nephrol Dial Transplant 33:514–522PubMed

66.

Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117–126PubMed

67.

Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334–S340PubMed

68.

Sakhaee K (2014) Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 27:241–245PubMedPubMedCentral

69.

Stern JM, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I, Burk R, Davies KP (2016) Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. Urolithiasis 44:399–407PubMed

70.

Mehta M, Goldfarb DS, Nazzal L (2016) The role of the microbiome in kidney stone formation. Int J Surg 36:607–612PubMedPubMedCentral

71.

Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A, Mancabelli L, Lugli GA, Turroni F, Duranti S, Mangifesta M, Viappiani A, Ferrario C, Dodi R, Dall'Asta M, Del Rio D, Ventura M, Meschi T (2018) Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67:2097–2106PubMed

72.

Liebman M, Al-Wahsh IA (2011) Probiotics and other key determinants of dietary oxalate absorption. Adv Nutr 2:254–260PubMedPubMedCentral

73.

Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41:318–322PubMed

74.

Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12:208–213PubMed

75.

Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMed

76.

Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMed

77.

Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A (2013) The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 83:1144–1149PubMed

78.

Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203PubMedPubMedCentral

79.

Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M (2009) A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int 103:18–21PubMed

80.

Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847PubMedPubMedCentral

81.

Hoppe B, Beck B, Gatter N (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305–1310PubMed

82.

Jairath A, Parekh N, Otano N, Mishra S, Ganpule A, Sabnis R, Desai M (2015) Oxalobacter formigenes: opening the door to probiotic therapy for the treatment of hyperoxaluria. Scand J Urol 49:334–337PubMed

83.

Milliner D, Hoppe B, Groothoff J (2018) A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis 46:313–323PubMed

84.

Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van't Hoff W, Moochhala SH, Deschênes G, Lindner E, Sjögren A, Cochat P (2017) A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Pediatr Nephrol 32:781–790PubMed

85.

Lieske JC, Goldfarb DS, De Simone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244–1249PubMed

86.

Goldfarb DS, Modersitzki F, Asplin JR (2007) A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2:745–749PubMed

87.

Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS (2010) Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int 78:1178–1185PubMedPubMedCentral

88.

Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105PubMed

89.

Suryavanshi MV, Bhute SS, Gune RP, Shouche YS (2018) Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease. Sci Rep 8:16598PubMedPubMedCentral

90.

Miller AW, Choy D, Penniston KL, Lange D (2019) Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis. Kidney Int 96:180–188PubMedPubMedCentral

91.

Zampini A, Nguyen AH, Rose E, Monga M, Miller AW (2019) Defining dysbiosis in patients with urolithiasis. Sci Rep 9:5425PubMedPubMedCentral

92.

Peck AB, Canales BK, Nguyen CQ (2016) Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease? Urolithiasis 44:45–50PubMed

93.

Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189:803–811PubMed

94.

Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75–88PubMed

95.

Khan SR (2014) Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol 3:256–276PubMedPubMedCentral

96.

Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A (2018) Dietary plants for the prevention and management of kidney stones: preclinical and clinical evidence and molecular mechanisms. Int J Mol Sci. 19:pii:E765

97.

Cealan A, Coman RT, Simon V, Andras I, Telecan T, Coman I, Crisan N (2019) Evaluation of the efficacy of Phyllanthus niruri standardized extract combined with magnesium and vitamin B6 for the treatment of patients with uncomplicated nephrolithiasis. Med Pharm Rep 92:153–157PubMedPubMedCentral

98.

Premgamone A, Sriboonlue P, Disatapornjaroen W et al (2001) A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health 32:654–660PubMed

99.

Singh RG, Behura SK, Kumar R (2010) Litholytic property of Kulattha (Dolichous biflorus) vs potassium citrate in renal calculus disease: a comparative study. J Assoc Physicians India 58:286–289PubMed

100.

Singh I, Bishnoi I, Agarwal V, Bhatt S (2011) Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤ 8 mm) nephrolithiasis. Urol Ann 3:75–81PubMedPubMedCentral

101.

Singh RG, Singh TB, Kumar R et al (2012) A comparative pilot study of litholytic properties of Celosia argental (Sitivaraka) versus potassium citrate in renal calculus disease. J Altern Complement Med 18:427–428PubMed

102.

Brardi S, Imperiali P, Cevenini G et al (2012) Effects of the association of potassium citrate and agropyrum repens in renal stone treatment: results of a prospective randomized comparison with potassium citrate. Arch Ital Urol Androl 84:61–67PubMed

103.

Monti E, Trinchieri A, Magri V, Cleves A, Perletti G (2016) Herbal medicines for urinary stone treatment. A systematic review. Arch Ital Urol Androl 88:38–46PubMed

104.

Patankar S, Dobhada S, Bhansali M et al (2008) A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation “varuna and banana stem” in the management of urinary stones. J Altern Complement Med 14:1287–1290PubMed

105.

Mohanty NK, Nayak RL, Patki PS (2010) Safety and efficacy of an Ayurvedic formulation Cystone in management of ureteric calculi: a prospective randomized placebo controlled study. Am J Pharmacol Toxicol 5:58–64

106.

Shekar Kumaran MG, Patki PS (2011) Evaluation of an Ayurvedic formulation (Cystone), in urolithiasis: a double blind, placebo-controlled study. Eur J Integr Med 3:23–28

107.

Upadhyay V, Malekar S, Deshpande S, Ahmad S, Shamsuddin (2011) Safety and efficacy of UNEX capsules in management of ureteric calculi: a prospective, randomised placebo-controlled study. Int J Green Pharm 5:346–349

108.

Ceban A (2012) Efficacy of a fixed combination of Centaurii herba, Levistici radix and Rosmarini folium in urinary lithiasis. Results of an open randomised cohort study. Z Phytother 33:19–23

109.

Faridi P, Seradj H, Mohammadi-Samani S, Vossoughi M, Mohagheghzadeh A, Roozbeh J (2014) Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. J Ethnopharmacol 156:82–87PubMed

110.

Rathod RB, Amilkanthwar RH (2015) The effect of Kadalikshar in the management of Mutrashmari (Urolithiasis). Int J Res Ajurveda Pharm 6:315–319

111.

Ardakani Movaghati MR, Yousefi M, Saghebi SA, Sadeghi Vazin M, Iraji A, Mosavat SH (2019) Efficacy of black seed (Nigella sativa L.) on kidney stone dissolution: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 33:1404–1412PubMed

112.

Erickson SB, Vrtiska TJ, Lieske JC (2011) Effect of Cystone® on urinary composition and stone formation over a one year period. Phytomedicine 18:863–867PubMedPubMedCentral

113.

Erickson SB, Vrtiska TJ, Canzanello VJ, Lieske JC (2011) Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res 39:197–203PubMed

114.

Micali S, Sighinolfi MC, Celia A et al (2006) Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 176:1020–1022PubMed

115.

Peng Y, Hu XH, Li X, Zhou GP (2010) Quantong recipe integrated with ureteroscopic laser lithotripsy for ureteral calculi. Zhong Xi Yi Jie He Xue Bao 8:530–534PubMed

116.

Kobayashi M, Naya Y, Kino M, Awa Y, Nagata M, Suzuki H, Yamaguchi K, Nozumi K, Ichikawa T (2008) Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 15:495–498PubMed

117.

Takada M, Yano H, Kanbara N, Kurita T, Kohri K, Kato Y, Iguchi M (1997) Effect of Chorei-to on spontaneous discharge of urinary stones after extracorporeal shock wave lithotripsy (ESWL). Hinyokika Kiyo 43:311–314PubMed

118.

Xiang W, Guo YL, Zhang JY, Zheng T, Zhang CH (2018) Curative effects of Ningmitai capsules on the residual fragments and postoperative complications following lithotripsy treatment of upper urinary calculi. Zhonghua Wai Ke Za Zhi 56:776–780PubMed

119.

Trinchieri A, Croppi E, Simonelli G, Sciorio C, Montanari E (2019) Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis. Urolithiasis. https://doi.org/10.1007/s00240-019-01138-w(Epub ahead of print) CrossRefPubMed

120.

Chae JY, Kim JW, Kim JW, Yoon CY, Park HS, du Moon G, Oh MM (2013) Increased fluid intake and adequate dietary modification may be enough for the successful treatment of uric acid stone. Urolithiasis 41:179–182PubMed

121.

Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR et al (2013) Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med 158:535–543PubMed

Titel: Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis
verfasst von: Renato Nardi Pedro
Asad Ullah Aslam
Jibril Oyekunle Bello
Kamran Hassan Bhatti
Joseph Philipraj
Idrissa Sissoko
Giovanna Souza Vasconcellos
Alberto Trinchieri
Noor Buchholz
Publikationsdatum: 02.03.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 4/2020
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-020-01182-x

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis

Abstract

Neu im Fachgebiet Urologie

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Trends in urinary calculi composition from 2005 to 2015: a single tertiary center study

Ureteral wall volume at ureteral stone site is a critical predictor for shock wave lithotripsy outcomes: comparison with ureteral wall thickness and area

Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy

Dual-frequency setting for urinary stone fragmentation during shock wave lithotripsy: an in vitro study

Editorial comment

Bone mineral density in adolescent urinary stone formers: is sex important?

Neu im Fachgebiet Urologie

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie